Viewing nowCMG Montelukast Chewable Tablets 5 mg (Montelukast Sodium)
Montelukast Sodium 5.2mg
Chewable Tablet · Prescription medication
CMG Pharmaceutical Co., Ltd.

MFDS item code 201905520 · Approved 2019.08.05 · Insurance code 648604340
Prevention of asthma and relief of symptoms of allergic rhinitis.
This medication helps prevent and treat asthma continuously. It is also used to relieve symptoms of seasonal and perennial allergic rhinitis.
Adults and adolescents aged 15 years and older take 10 mg of montelukast orally once daily. This medication should be taken once daily; asthma patients should take it in the evening, while allergic rhinitis patients should determine the timing based on their condition. Patients with both asthma and allergic rhinitis should take 1 tablet in the evening once daily. This medication should be taken 1 hour before meals or 2 hours after meals.
Children aged 6 to 14 years take 5 mg of montelukast once daily by chewing. Children aged 2 to 5 years take 4 mg of montelukast once daily by chewing. This medication should be taken 1 hour before meals or
This medication is used for the treatment of asthma and allergic rhinitis. During treatment with this medication, significant neuropsychiatric symptoms may occur, so patients and caregivers should closely monitor for changes in mental state such as agitation, anxiety, depression, hallucinations, and suicidal thoughts. If new neuropsychiatric symptoms or behavioral changes occur, discontinue use immediately and consult a physician. This medication contains the artificial sweetener aspartame, so patients with a genetic disorder called phenylketonuria should avoid it and also limit their intake of aspartame. For formulations containing lactose, it should not be administered to patients with genetic issues such as lactose intolerance or galactose intolerance. This medication is not an emergency treatment for acute asthma attacks, so appropriate emergency medications should always be carried and used in the event of acute symptoms. While taking this medication, the dosage of inhaled corticosteroids may be adjusted according to a physician's instructions, but sudden changes are prohibited. It should not be used alone to treat exercise-induced bronchospasm; inhaled beta-agonists should be used in combination as needed. Patients with hypersensitivity to aspirin or nonsteroidal anti-inflammatory drugs should avoid using those medications while taking this product. Rarely, various adverse reactions may occur, including those affecting blood, liver, nervous system, and skin, so if any unusual symptoms arise, consult a physician immediately. Pregnant or breastfeeding women should exercise caution when taking this medication, especially during pregnancy, and should only take it if absolutely necessary. Children and the elderly should also be monitored for safety, especially as the safety and efficacy for children under 6 months of age have not been established. In cases of overdose, there is no specific antidote, and general symptomatic treatment and clinical monitoring are necessary. Keep the medication out of reach of children and avoid transferring it to other containers. This medication should be taken consistently even when asthma symptoms are not present, and if symptoms worsen, consult your physician promptly.
Hives, severe swelling (edema), angioedema, chest tightness, difficulty breathing, cold sweat, paleness, severe allergic reactions, severe rashes, blisters, skin peeling, pain in oral/ocular mucosa, toxic epidermal necrolysis, Stevens-Johnson syndrome, severe skin adverse reactions, shortness of breath or difficulty breathing, asthma attacks, respiratory issues accompanying cough and fever, respiratory problems, jaundice (yellowing of skin or eyes), severe overall
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to moisture and light, so it should be stored at room temperature between 1°C and 30°C. It is important to keep it in a tightly sealed container to prevent air exposure.
Pink chewable tablet with a biconvex round shape.
28 tablets (4 PTPs of 7 tablets each)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowMontelukast Sodium 5.2mg
Chewable Tablet · Prescription medication
CMG Pharmaceutical Co., Ltd.

Montelukast Sodium 5.2mg
Chewable Tablet · Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 10.4mg
Tablet · Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Korea Organon Co., Ltd.
Montelukast Sodium 4.16mg
Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 10.4mg
Tablet · Prescription medication
JW Pharmaceutical Co., Ltd.

Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Samil Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.